My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 371

    1.

    Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.

    Wannamethee SG, Sattar N, Rumley A, Whincup PH, Lennon L, Lowe GD.

    Diabetes Care. 2008 May;31(5):995-1000. Epub 2008 Jan 30.PMID: 18235054 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.

    Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH.

    Diabetes Care. 2002 Aug;25(8):1340-5.PMID: 12145232 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adipokines and risk of type 2 diabetes in older men.

    Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N.

    Diabetes Care. 2007 May;30(5):1200-5. Epub 2007 Feb 23.PMID: 17322479 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.

    Meigs JB, O'donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW.

    Diabetes. 2006 Feb;55(2):530-7.PMID: 16443791 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

    Wannamethee SG, Shaper AG, Lennon L, Whincup PH.

    Diabetes Care. 2005 Dec;28(12):2913-8.PMID: 16306554 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

    Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS.

    Diabetes Care. 2003 Jun;26(6):1745-51.PMID: 12766104 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men.

    Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH.

    Atherosclerosis. 2005 Jul;181(1):101-8.PMID: 15939060 [PubMed - indexed for MEDLINE]Related articles

    8.

    Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study.

    Frankel DS, Meigs JB, Massaro JM, Wilson PW, O'Donnell CJ, D'Agostino RB, Tofler GH.

    Circulation. 2008 Dec 9;118(24):2533-9. Epub 2008 Nov 24.PMID: 19029465 [PubMed - indexed for MEDLINE]Related articles

    9.

    A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease.

    Woodward M, Rumley A, Welsh P, MacMahon S, Lowe G.

    J Thromb Haemost. 2007 Sep;5(9):1795-800.PMID: 17723116 [PubMed - indexed for MEDLINE]Related articles

    10.

    Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.

    May M, Lawlor DA, Patel R, Rumley A, Lowe G, Ebrahim S.

    Eur J Cardiovasc Prev Rehabil. 2007 Oct;14(5):638-45.PMID: 17925622 [PubMed - indexed for MEDLINE]Related articles

    11.

    Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis.

    Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH.

    Am J Clin Nutr. 2006 Mar;83(3):567-74; quiz 726-7.PMID: 16522902 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study.

    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

    Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):3071-8.PMID: 10591689 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease.

    Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM, Sattar N.

    Atherosclerosis. 2007 Apr;191(2):418-26. Epub 2006 May 19.PMID: 16712853 [PubMed - indexed for MEDLINE]Related articles

    14.

    Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

    André P, Balkau B, Born C, Charles MA, Eschwège E; D.E.S.I.R. study group.

    Diabetologia. 2006 Nov;49(11):2599-603. Epub 2006 Sep 13.PMID: 16969645 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population.

    Rudnicka AR, Rumley A, Lowe GD, Strachan DP.

    Circulation. 2007 Feb 27;115(8):996-1003. Epub 2007 Feb 12.PMID: 17296859 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

    Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C.

    Diabetes Care. 2007 Apr;30(4):854-60.PMID: 17392546 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study.

    Becker A, Van Hinsbergh VW, Kostense PJ, Jager A, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD.

    Eur J Clin Invest. 2000 Sep;30(9):763-70.PMID: 10998075 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men.

    Wannamethee SG, Whincup PH, Rumley A, Lowe GD.

    J Thromb Haemost. 2007 Aug;5(8):1637-43. Epub 2007 Jun 1.PMID: 17596140 [PubMed - indexed for MEDLINE]Related articles

    19.

    Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.

    Niessner A, Graf S, Nikfardjam M, Speidl WS, Huber-Beckmann R, Zorn G, Wojta J, Huber K.

    Thromb Haemost. 2003 Aug;90(2):344-50.PMID: 12888883 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.

    Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Döring A, Löwel H, Koenig W; MONICA/KORA Study Group.

    Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):398-405. Epub 2005 Dec 1.PMID: 16322530 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity